Overall, our results showed that Sal-induced ESR2 expression worked complimentarily with Tamo to promote an anticancer effect, suggesting a novel targeted treatment approach for BC lacking of clinically-relevant biomarker, such as TNBC. This evidence concerns the gene ESR2 and breast cancer.